UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 250

Sortiert nach

Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials

Journal of clinical oncology, 2015-03, Vol.33 (8), p.910-915

2015

Volltextzugriff (PDF)

Biological characterization and selection criteria of adjuvant chemotherapy for early breast cancer: experience from the Italian observational NEMESI study

BMC cancer, 2012-06, Vol.12 (1), p.216-216, Article 216

2012

Volltextzugriff (PDF)

Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer

Endocrine-related cancer, 2005-12, Vol.12 (4), p.721-747

2005

Volltextzugriff (PDF)

Endocrine Effects of Adjuvant Letrozole Compared With Tamoxifen in Hormone-Responsive Postmenopausal Patients With Early Breast Cancer: The HOBOE Trial

Journal of clinical oncology, 2009-07, Vol.27 (19), p.3192-3197

2009

Volltextzugriff (PDF)

Compliance and toxicity of adjuvant CMF in elderly breast cancer patients: a single-center experience

BMC cancer, 2005-03, Vol.5 (1), p.30-30, Article 30

2005

Volltextzugriff (PDF)

Topotecan Compared With No Therapy After Response to Surgery and Carboplatin/Paclitaxel in Patients With Ovarian Cancer: Multicenter Italian Trials in Ovarian Cancer (MITO-1) Randomized Study

Journal of clinical oncology, 2004-07, Vol.22 (13), p.2635-2642

2004

Volltextzugriff (PDF)

Endocrine Effects of Adjuvant Letrozole + Triptorelin Compared With Tamoxifen + Triptorelin in Premenopausal Patients With Early Breast Cancer

Journal of clinical oncology, 2008-01, Vol.26 (2), p.264-270

2008

Volltextzugriff (PDF)

An osmotic computing infrastructure for urban pollution monitoring

Software, practice & experience, 2020-05, Vol.50 (5), p.533-557

2020

Volltextzugriff (PDF)

Effects on quality of life of weekly docetaxel-based chemotherapy in patients with locally advanced or metastatic breast cancer: results of a single-centre randomized phase 3 trial

BMC cancer, 2011-02, Vol.11 (1), p.75-75, Article 75

2011

Volltextzugriff (PDF)

Time to Progression in Metastatic Breast Cancer Patients Treated With Epirubicin Is Not Improved by the Addition of Either Cisplatin or Lonidamine: Final Results of a Phase III Study With a Factorial Design

Journal of clinical oncology, 2002-10, Vol.20 (20), p.4150-4159

2002

Volltextzugriff (PDF)

Detection of Circulating Tumor Cells in Carcinoma Patients by a Novel Epidermal Growth Factor Receptor Reverse Transcription-PCR Assay

Clinical cancer research, 2000-04, Vol.6 (4), p.1439-1444

2000

Volltextzugriff (PDF)

Vinorelbine plus 3-weekly trastuzumab in metastatic breast cancer: a single-centre phase 2 trial

BMC cancer, 2007-03, Vol.7 (1), p.50-50, Article 50

2007

Volltextzugriff (PDF)

MPA increases idarubicin-induced apoptosis in chronic lymphatic leukaemia cells via caspase-3

Journal of cellular biochemistry, 2003-07, Vol.89 (4), p.747-754

2003

Volltextzugriff (PDF)

Modulating effect of lonidamine on response to doxorubicin in metastatic breast cancer patients : Results from a multicenter prospective randomized trial

Breast cancer research and treatment, 1998-06, Vol.49 (3), p.209-217

1998

Volltextzugriff (PDF)

Comparing SLAs for Cloud Services: A Model for Reasoning

New Trends in Databases and Information Systems, p.178-190

Volltextzugriff (PDF)

Increased overall survival independent of RECIST response in metastatic breast cancer patients continuing trastuzumab treatment: evidence from a retrospective study

Breast cancer research and treatment, 2011-07, Vol.128 (1), p.147-154

2011

Volltextzugriff (PDF)

Payment Cards and Permitted Multilateral Interchange Fees (MIFs): Will the European Commission Harm Consumers and the European Payment Industry?

Journal of European competition law & practice, 2015-02, Vol.6 (2), p.85-95

2015

Volltextzugriff (PDF)

Reply to P.E. Lønning et al

Journal of clinical oncology, 2010-02, Vol.28 (6), p.e103-e104

2010

Volltextzugriff (PDF)

Primary Chemotherapy with Epirubicin and Vinorelbine in Women with Locally Advanced Breast Cancer

Anticancer research, 2005-03, Vol.25 (2B), p.1343-1348

2005

Volltextzugriff (PDF)

Dose‐Dense FEC Followed by Dose‐Dense Ixabepilone as Neoadjuvant Treatment for Breast Cancer Patients: A Feasibility Study

The oncologist (Dayton, Ohio), 2013-08, Vol.18 (8), p.924-925

2013

Volltextzugriff (PDF)

Dose‐Dense FEC Followed by Dose‐Dense Ixabepilone as Neoadjuvant Treatment for Breast Cancer Patients: A Feasibility Study

The oncologist (Dayton, Ohio), 2013-10, Vol.18 (10), p.1149-1149

2013

Volltextzugriff (PDF)

First‐Line Chemotherapy for HER‐2–Negative Metastatic Breast Cancer Patients Who Received Anthracyclines as Adjuvant Treatment

The oncologist (Dayton, Ohio), 2007-11, Vol.12 (11), p.1288-1298

2007

Volltextzugriff (PDF)

Urban Pollution Monitoring Based on Mobile Crowd Sensing: An Osmotic Computing Approach

2018 IEEE 4th International Conference on Collaboration and Internet Computing (CIC), 2018, p.380-387

2018

Volltextzugriff (PDF)

1 – 25 von 250

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(199)
Mit Volltextzugriff
(212)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(179)
Life Sciences & Biomedicine
(115)
Humans
(78)
Technology
(55)
Female
(53)
Engineering
(48)
Engineering, Electrical & Electronic
(41)
Middle Aged
(40)
Adult
(35)
Aged
(35)
Male
(34)
Oncology
(34)
Physical Sciences
(23)
Breast Neoplasms - Drug Therapy
(22)
Treatment Outcome
(20)
Cmos
(19)
Sensors
(18)
Biological And Medical Sciences
(17)
Medical Sciences
(17)
Computer Science
(16)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials

Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial

Biological characterization and selection criteria of adjuvant chemotherapy for early breast cancer: experience from the Italian observational NEMESI study

Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer

Endocrine Effects of Adjuvant Letrozole Compared With Tamoxifen in Hormone-Responsive Postmenopausal Patients With Early Breast Cancer: The HOBOE Trial

Compliance and toxicity of adjuvant CMF in elderly breast cancer patients: a single-center experience

Topotecan Compared With No Therapy After Response to Surgery and Carboplatin/Paclitaxel in Patients With Ovarian Cancer: Multicenter Italian Trials in Ovarian Cancer (MITO-1) Randomized Study

Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: the Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study

Endocrine Effects of Adjuvant Letrozole + Triptorelin Compared With Tamoxifen + Triptorelin in Premenopausal Patients With Early Breast Cancer

An osmotic computing infrastructure for urban pollution monitoring

Effects on quality of life of weekly docetaxel-based chemotherapy in patients with locally advanced or metastatic breast cancer: results of a single-centre randomized phase 3 trial

Time to Progression in Metastatic Breast Cancer Patients Treated With Epirubicin Is Not Improved by the Addition of Either Cisplatin or Lonidamine: Final Results of a Phase III Study With a Factorial Design

Detection of Circulating Tumor Cells in Carcinoma Patients by a Novel Epidermal Growth Factor Receptor Reverse Transcription-PCR Assay

Vinorelbine plus 3-weekly trastuzumab in metastatic breast cancer: a single-centre phase 2 trial

MPA increases idarubicin-induced apoptosis in chronic lymphatic leukaemia cells via caspase-3

Modulating effect of lonidamine on response to doxorubicin in metastatic breast cancer patients : Results from a multicenter prospective randomized trial

Comparing SLAs for Cloud Services: A Model for Reasoning

Increased overall survival independent of RECIST response in metastatic breast cancer patients continuing trastuzumab treatment: evidence from a retrospective study

Payment Cards and Permitted Multilateral Interchange Fees (MIFs): Will the European Commission Harm Consumers and the European Payment Industry?

Reply to P.E. Lønning et al

Primary Chemotherapy with Epirubicin and Vinorelbine in Women with Locally Advanced Breast Cancer

Dose‐Dense FEC Followed by Dose‐Dense Ixabepilone as Neoadjuvant Treatment for Breast Cancer Patients: A Feasibility Study

Dose‐Dense FEC Followed by Dose‐Dense Ixabepilone as Neoadjuvant Treatment for Breast Cancer Patients: A Feasibility Study

First‐Line Chemotherapy for HER‐2–Negative Metastatic Breast Cancer Patients Who Received Anthracyclines as Adjuvant Treatment

Urban Pollution Monitoring Based on Mobile Crowd Sensing: An Osmotic Computing Approach

Suchergebnisse filtern